Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Omalizumab on Food Allergy in Children With Severe Asthma: A Real Life Study

NCT06316414 is registered in ClinicalTrials.gov with Bambino Gesù Hospital and Research Institute as lead sponsor.

NCT NCT06316414
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06316414 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Omalizumab on Food Allergy in Children With Severe Asthma: A Real Life Study
Lead sponsor
Bambino Gesù Hospital and Research Institute
Phase
Observational
Overall status
Completed
Start date
January 1, 2018
Completion date
March 31, 2023
Enrollment
65 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asthma in children, food; allergy, anaphylactic shock